We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Photoacoustic Imaging Ensures Complete Cancer Removal

By MedImaging International staff writers
Posted on 14 Jun 2017
Print article
Image: Photoacoustic imaging (R) produces images as detailed and accurate as traditional methods (L) (Photo courtesy of Terence Wong / WUSTL).
Image: Photoacoustic imaging (R) produces images as detailed and accurate as traditional methods (L) (Photo courtesy of Terence Wong / WUSTL).
A novel technology that combines light and sound can scan tissue samples to produce images detailed and accurate enough to determine whether a tumor has been completely removed.

Developed by researchers at Washington University School of Medicine (WUSTL; St. Louis, MO, USA), and the California Institute of Technology (Caltech; Pasadena, USA) photoacoustic microscopy (PAM) can scan an unprepared sample of breast tissue in the operating theater, producing images of sufficient quality to detect tumor features and margins. PAM takes advantage of the intrinsic optical contrast of breast tissue in order to achieve multilayered, histology-like imaging of the tissue surface.

According to the researchers, the high correlation of the PAM images to conventional histologic images allows rapid computations of diagnostic features such as nuclear size and packing density, potentially identifying small clusters of cancer cells. And since PAM does not require tissue processing or staining, it can be performed promptly and intraoperatively, enabling immediate directed re-excision, reducing the number of second surgeries. The study was published on May 17, 2017, in Science Advances.

“Overall, the photoacoustic images had a lot of the same features that we see with standard staining, which means we can use the same criteria to interpret the photoacoustic imaging. We don’t have to come up with new criteria,” said co-senior author Deborah Novack, MD, PhD, of WUSTL. “It’s the pattern of cells – their growth pattern, their size, their relationship to one another – that tells us if this is normal tissue or something malignant.”

“All molecules absorb light at some wavelength; this is what makes photoacoustic imaging so powerful. Essentially, you can see any molecule, provided you have the ability to produce light of any wavelength,” said co-senior author biomedical engineering Lihong Wang, PhD, of Caltech. “None of the other imaging technologies can do that. Ultrasound will not do that; X-rays will not do that; light is the only tool that allows us to provide biochemical information.”

Photoacoustic imaging uses non-ionizing laser pulses delivered into biological tissues. Some of the delivered energy is absorbed and converted into heat, leading to transient thermoelastic expansion, and thus wideband ultrasonic emission, which can be detected by ultrasonic transducers and analyzed to produce images. The magnitude of the photoacoustic signal is proportional to local energy deposition, which can be demonstrated by optical absorption contrast on the images of the targeted areas.

Related Links:
Washington University School of Medicine
California Institute of Technology
New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology
Portable Color Doppler Ultrasound Scanner
DCU10
New
Radiation Shielding
Oversize Thyroid Shield
New
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices

Print article

Channels

MRI

view channel
Image: The AI tool can help interpret and assess how well treatments are working for MS patients (Photo courtesy of Shutterstock)

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans

Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.